Tomografía por emisión de positrones marcada con 18-Fluor-dihidroxifenilalanina para el diagnóstico de feocromocitoma

Ramós-Leví, Ana María; Díaz Pérez, Ángel; Molino, Ángel; Ochagavía, Santiago.
Endocrinol. nutr. (Ed. impr.) ; 60(6): 336-338, jun.-jul. 2013. ilus
Artículo en Español | IBECS (España) | ID: ibc-114614

Documentos relacionados

  1. Slowing of EEG waves correlates with striatal [<sup>18</sup> F]fluorodopa PET/CT uptake and executive dysfunction in Parkinson's disease.
  2. Toward imaging of alpha-synuclein with PET.
  3. Evaluation of adrenal masses using 18 F-FDOPA PET/CT in patients suspected with pheochromocytoma.
  4. Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications.
  5. Preliminary evaluation of GLP-1R PET in the diagnosis and risk stratification of pheochromocytomas.
  6. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
  7. Beyond Visual Assessment of Basal Ganglia Uptake: Can Automated Method and Pineal Body Uptake Assessment Improve Identification of Nigrostriatal Dysfunction on <sup>18</sup>F-DOPA PET/CT?
  8. Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols.
  9. Organocatalytic Asymmetric Synthesis of SynVesT-1, a Synaptic Density Positron Emission Tomography Imaging Agent.
  10. Quantitation of dynamic total-body PET imaging: recent developments and future perspectives.